Loading organizations...
Ganymed Robotics is a Paris, France-based medical device company that develops advanced robotic assistance technologies and computer vision software specifically designed for orthopedic surgeons performing joint replacement procedures. The organization's proprietary platform combines robotic assistance with image guidance and clinical decision tools to improve surgical efficiency and patient outcomes in total knee arthroplasty interventions. Operating with a team of 30 employees, the enterprise recently completed a 100-patient observational study to validate its technology and secured a robust patent portfolio. To fund the industrialization of its first commercial device through strategic manufacturing partnerships, the company raised €36 million in Series B financing. This capital was provided by a syndicate of institutional investors that includes Cathay Health, The European Innovation Council Fund, Cap Horn, and Kurma Partners. Ganymed Robotics was founded in 2018 by current chief executive officer Sophie Cahen.
Ganymed Robotics has raised $40.0M across 3 funding rounds.
Ganymed Robotics has raised $40.0M in total across 3 funding rounds.
Ganymed Robotics has raised $40.0M in total across 3 funding rounds.
Ganymed Robotics's investors include European Innovation Council, Alexandre Heraud, Bpifrance, Stephen Oesterle, BNP Paribas Développement, Credit Mutuel Innovation, Kurma Partners.
Ganymed Robotics has raised $40.0M across 3 funding rounds. Most recently, it raised $2.7M Grant in March 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 25, 2024 | $2.7M Grant | European Innovation Council | — | Announced |
| Jan 4, 2023 | $15.9M Debt Financing | Alexandre Heraud, European Innovation Council | Bpifrance | Announced |
| Jul 7, 2022 | $21.4M Series B | Stephen Oesterle | BNP Paribas Développement, Credit Mutuel Innovation, Kurma Partners | Announced |
